Second-line Chemotherapy for Advanced Bladder Cancer: Taxanes Versus Vinflunine

Second-line Chemotherapy for Advanced Bladder Cancer: Taxanes Versus Vinflunine

Aim: Second-line chemotherapy in advanced urothelial carcinoma (UC) remains a significant clinical challenge, with limited high-level evidence guiding regimen selection. Vinflunine is the only agent approved by the European Medicines Agency for this setting, while taxanes are widely used off-label b...

Full description

Saved in:
Bibliographic Details
Main Authors: Bilgin Demir, Ali Aytaç, Gökhan Çolak, Onur Yazdan Balçık, Ömer Acar
Format: Article
Language:English
Published: Galenos Publishing House 2025-08-01
Series:Acta Haematologica Oncologica Turcica
Subjects:
urothelial carcinoma
second-line chemotherapy
taxanes
vinflunine
Online Access:https://www.actaoncologicaturcica.com/articles/second-line-chemotherapy-for-advanced-bladder-cancer-taxanes-versus-vinflunine/doi/ahot.galenos.2025.2025-7-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.actaoncologicaturcica.com/articles/second-line-chemotherapy-for-advanced-bladder-cancer-taxanes-versus-vinflunine/doi/ahot.galenos.2025.2025-7-2

Similar Items